Bexson Biomedical
Bexson Biomedical develops precision-driven therapies for central nervous system (CNS) disorders, focusing on pain and mental health. The company is advancing a pipeline of subcutaneous drug formulations, led by an IND-ready ketamine compound for moderate/severe acute pain. Bexson also develops wearable, programmable delivery devices to enable controlled, scalable drug administration both in clinical and field settings. Their technology targets unmet needs in pain management, neuropsychiatric conditions, and military medicine.
Industries
N/A
Patents
Complexing agent salt formulations of pharmaceutical compounds
2025-11-18 • US-12472201-B2
View DetailsComplexing agent salt formulations of pharmaceutical compounds
2022-12-27 • US-11534454-B2
View Details
Complexing agent salt formulations of pharmaceutical compounds
2025-11-18 • US-12472201-B2
View DetailsComplexing agent salt formulations of pharmaceutical compounds
2022-12-27 • US-11534454-B2
View DetailsProducts
A pre-filled, pre-sterilized, Bluetooth-enabled device for programmable, controlled release of subcutaneous therapeutics, including ketamine and other compounds.
A proprietary ketamine salt compound optimized for subcutaneous delivery, achieving high bioavailability and improved tolerance.
Ruggedized wearable drug delivery device optimized for field use, providing rapid, programmable subcutaneous administration for pain, overdose prevention, and battlefield bleeding.
A pre-filled, pre-sterilized, Bluetooth-enabled device for programmable, controlled release of subcutaneous therapeutics, including ketamine and other compounds.
A proprietary ketamine salt compound optimized for subcutaneous delivery, achieving high bioavailability and improved tolerance.
Ruggedized wearable drug delivery device optimized for field use, providing rapid, programmable subcutaneous administration for pain, overdose prevention, and battlefield bleeding.
Expertise Areas
- CNS therapy development
- Wearable drug delivery technology
- Clinical-stage drug formulation
- Military medical device adaptation
Key Technologies
- Subcutaneous drug delivery systems
- Programmable electromechanical pumps
- Bluetooth-enabled medical devices
- High-concentration, isotonic drug formulations
Key People
Chief Executive Officer
Co-Founder, Chief Scientific Officer
EVP Drug Delivery
EVP Process Development & Manufacturing
SVP Quality & Regulatory
Head of Medicinal Chemistry
Chief Executive Officer
Co-Founder, Chief Scientific Officer
EVP Drug Delivery
EVP Process Development & Manufacturing
SVP Quality & Regulatory
Head of Medicinal Chemistry
News & Updates
Received for collaborative development of a wearable on-body delivery system.
Peer-reviewed publication demonstrating the safety profile of the subcutaneous ketamine formulation.
Discussion of the approach to building wearable, programmable drug delivery devices for pain management.
Forbes article analyzing the potential impact of wearable ketamine delivery systems in pain therapy.
Device evaluated by all five U.S. military branches in August 2023.
Field-optimized device presented to U.S. military innovation leaders.
Received for collaborative development of a wearable on-body delivery system.
Peer-reviewed publication demonstrating the safety profile of the subcutaneous ketamine formulation.
Discussion of the approach to building wearable, programmable drug delivery devices for pain management.
Forbes article analyzing the potential impact of wearable ketamine delivery systems in pain therapy.
Device evaluated by all five U.S. military branches in August 2023.
Field-optimized device presented to U.S. military innovation leaders.